Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 14/20 | 0.38 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.34 |
| ▸ | FEN1 | P39748 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 4/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.32 |
| ▸ | CTSD | P07339 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13487797 | 0.96 | PDK2 (0.36) | PDK2ALOX5APFEN1BACE1KCNH2 | |
| SCHEMBL13487903 | 0.96 | PDK2 (0.38) | PDK2ALOX5APFEN1BACE1KCNH2 | |
| SCHEMBL13488054 | 0.93 | CYP11B1 (0.36) | PDK2ALOX5APFEN1 | |
| SCHEMBL13487361 | 0.92 | PDK2 (0.39) | PDK2ALOX5APFEN1BACE1KCNH2 | |
| SCHEMBL13487809 | 0.92 | PDK2 (0.36) | PDK2ALOX5APFEN1 | |
| SCHEMBL13487979 | 0.91 | ENPP3 (0.34) | PDK2ALOX5APFEN1BACE1 | |
| SCHEMBL13487518 | 0.89 | ATM (0.36) | PDK2BACE1KCNH2 | |
| SCHEMBL13488129 | 0.88 | PDK2 (0.49) | PDK2BACE1KCNH2 | |
| SCHEMBL15977617 | 0.87 | PDK2 (0.51) | PDK2BACE1KCNH2 | |
| SCHEMBL13487665 | 0.86 | CYP11B2 (0.36) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100045170-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-25 | — | — | US | disclosed |
| US-20100045170-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100045170-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | PDK2 1456/4885ALOX5AP 230/4885FEN1 1389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.